Research indicates creatine injections enhance dendritic cell activity and slow tumor growth — Evidence Review
Published in iScience, by researchers from UCLA
Researched by
— the AI search engine for science
Table of Contents
Creatine, a popular workout supplement, was found by UCLA researchers to enhance both killer T cells and dendritic cells in mouse models, boosting anti-cancer immune responses. While related studies show mixed effects of creatine on cancer, some support its immune-modulating potential and others raise caution about possible risks of tumor progression or metastasis.
- Several studies indicate that creatine can slow tumor growth and modulate immune responses, both by supporting immune cell energy needs and by reducing inflammation, though these effects do not always translate into improved survival 2 13 14.
- Other research suggests creatine metabolism may aid tumor cells directly or promote metastasis in certain cancer models, especially when creatine is taken up by tumor cells rather than immune cells 1 3 4 5.
- The new findings that creatine enhances dendritic cell function align with recent reviews highlighting the importance of dendritic cells in immunotherapy success, suggesting a potential avenue for improving immune-based cancer treatments 6 7 8 9 10.
Study Overview and Key Findings
The new study addresses a major limitation in cancer immunotherapy: its limited effectiveness across patient populations. While immunotherapies have revolutionized cancer treatment, only a minority of patients experience lasting benefits, often due to insufficient activation of the immune system. This research explores whether creatine, a common dietary supplement, can bolster the function of dendritic cells—the immune “sentinels” that prime killer T cells to mount anti-tumor attacks—thereby potentially enhancing the efficacy of immunotherapies.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | UCLA |
| Journal Name | iScience |
| Authors | Elliot Kang, James Elsten-Brown, Yu-Chen Wang, Ashley Lam, Elise Sanchez, Renee Wen, Tiffany Wang, Jennifer Chiang, Quentin Scarborough, Yan-Ruide Li, Yichen Zhu, Jie Huang, Matthew Williams, Sarah Eckl, Bo Li, Lili Yang |
| Population | Mouse models, human cells |
| Outcome | Dendritic cell activation, T cell activity, tumor growth |
| Results | Creatine injections slowed tumor growth and enhanced dendritic cell activity. |
Literature Review: Related Studies
To contextualize these findings, we searched the Consensus paper database, which includes over 200 million research papers. We used the following queries to identify relevant studies:
- creatine injections tumor growth effects
- dendritic cells cancer immunotherapy enhancement
- workout supplements immune response cancer
Below, we summarize the key findings from related studies, grouped into major research topics:
| Topic | Key Findings |
|---|---|
| What are the effects of creatine on tumor growth and metastasis? | - Creatine supplementation can slow tumor growth in some models, potentially through anti-inflammatory and metabolic mechanisms 2 13 14. - However, creatine metabolism and uptake by tumor cells can also promote tumor progression or metastasis in certain cancer types 1 3 4 5. |
| How do dendritic cells influence cancer immunotherapy outcomes? | - Dendritic cells are critical for initiating anti-tumor T cell responses and are key determinants of immunotherapy success 6 7 8 9 10. - Enhancing dendritic cell activation or function can improve the efficacy of immunotherapies, including checkpoint inhibitors and vaccines 6 7 8 10. |
| Can lifestyle interventions like exercise or supplements modulate anti-cancer immunity? | - Exercise and physical activity can enhance immune function, reduce inflammation, and may improve response to immunotherapy in cancer patients 11 12 13 14 15. - Some exercise-induced benefits are mediated by improved dendritic cell and T cell function 12 13 14 15. |
What are the effects of creatine on tumor growth and metastasis?
Studies show that creatine’s impact on cancer is complex, with both anti-tumor and pro-tumor effects depending on the context. Some experimental models demonstrate that creatine supplementation slows tumor growth and reduces inflammation, but other research indicates that creatine may support tumor cell metabolism and promote metastasis in certain cancers.
- Creatine supplementation reduced tumor growth in rodent models, possibly by restoring metabolic balance and reducing pro-inflammatory cytokines 2.
- Tumor cells can upregulate creatine transporters, importing creatine to support their own energy needs, which may enhance tumor progression, especially in metabolically active or hypoxic microenvironments 1 3 4.
- In some settings, creatine supplementation promoted metastasis and shortened survival, particularly in breast and colorectal cancer models 5.
- The dual role of creatine—supporting both immune cells and, in some cases, tumor cells—highlights the need for context-specific research and caution when considering supplementation in oncology 1 2 3 4 5.
How do dendritic cells influence cancer immunotherapy outcomes?
The function and activation status of dendritic cells are pivotal for effective anti-tumor immune responses. Recent reviews and studies emphasize that dendritic cells orchestrate T cell priming and are necessary for the success of modern immunotherapies.
- Different dendritic cell subsets play central roles in sensing tumor antigens and activating adaptive immune responses 6 7 8 9 10.
- The tumor microenvironment can suppress dendritic cell function, limiting the effectiveness of immunotherapies; strategies to boost dendritic cell activity are actively being explored 6 8 9 10.
- Personalized dendritic cell vaccines, when optimized, have shown promise in clinical and preclinical settings 7 9.
- The new study’s finding that creatine enhances dendritic cell activation is consistent with the recognized importance of dendritic cells in cancer immunotherapy 6 7 8 9 10.
Can lifestyle interventions like exercise or supplements modulate anti-cancer immunity?
A growing body of literature supports the idea that lifestyle factors—including exercise and certain supplements—can positively affect immune function in cancer patients and survivors. These interventions may reduce inflammation, mobilize immune cells, and improve response to cancer therapies.
- Exercise reduces pro-inflammatory markers and may enhance immune cell proportions and function in cancer survivors, with the most pronounced effects seen in combined aerobic and resistance training 11 14.
- Exercise training can lower cancer recurrence risk and improve outcomes, in part by enhancing the anti-tumor immune response and improving the efficacy of standard treatments 12 13 15.
- Some benefits of exercise are mediated by dendritic cell and T cell activation, which aligns with the mechanism explored in the new creatine study 12 13 14 15.
- While creatine is a common supplement among athletes, its role as an immune modulator in oncology remains under investigation, with both potential benefits and risks identified 2 5 15.
Future Research Questions
While the current study offers promising evidence that creatine can support anti-cancer immunity by energizing dendritic cells, substantial questions remain. Further research is needed to determine the safety, efficacy, and mechanisms of creatine supplementation in human cancer patients, as well as to clarify its effects across different tumor types and clinical contexts.
| Research Question | Relevance |
|---|---|
| Does creatine supplementation improve cancer immunotherapy outcomes in humans? | Human clinical trials are needed to determine whether the immune-boosting effects observed in mice translate to improved outcomes for patients undergoing immunotherapy 2 6 8. |
| What is the risk of creatine promoting tumor growth or metastasis in certain cancers? | Some studies indicate that creatine may support tumor progression or metastasis under specific conditions, highlighting the need to identify which cancer types or patient populations may be at risk 1 3 4 5. |
| What are the mechanisms underlying creatine's effects on dendritic cell activation? | Understanding how creatine enhances dendritic cell function at the molecular level could inform the development of safer and more targeted immunotherapeutic strategies 6 7 10. |
| How does creatine affect different subsets of dendritic cells in the tumor microenvironment? | Dendritic cells are highly heterogeneous, and the impact of creatine on various DC subsets could influence both efficacy and safety of supplementation in cancer therapy 7 9 10. |
| Can creatine be safely incorporated into dendritic cell-based vaccine manufacturing? | The study suggests creatine may enhance the potency of dendritic cell vaccines, but further research is needed to evaluate safety, dosing, and clinical impact in humans 7 9. |
This article presents a balanced synthesis of current evidence, highlighting both the promise and potential risks of creatine supplementation as an adjunct to cancer immunotherapy. Further studies, particularly well-designed human clinical trials, are essential to clarify its role and safety in cancer care.